David Raben insider trades

Open-market stock purchases and sales by David Raben, Chief Medical Officer at Bicara Therapeutics Inc, from SEC Form 4 filings since Oct 9, 2025.

Recent trades

DateStockTradeValue
Apr 27, 2026BCAX Bicara Therapeutics IncSold$126K
Apr 27, 2026BCAX Bicara Therapeutics IncBought (not open market)—
Mar 25, 2026BCAX Bicara Therapeutics IncSold$104K
Mar 25, 2026BCAX Bicara Therapeutics IncBought (not open market)—
Mar 4, 2026BCAX Bicara Therapeutics IncSold$302K
Mar 4, 2026BCAX Bicara Therapeutics IncBought (not open market)—
Mar 3, 2026BCAX Bicara Therapeutics IncBought (not open market)—
Mar 3, 2026BCAX Bicara Therapeutics IncSold$3.7K
Feb 2, 2026BCAX Bicara Therapeutics IncBought (not open market)—
Dec 26, 2025BCAX Bicara Therapeutics IncBought (not open market)—
Nov 25, 2025BCAX Bicara Therapeutics IncSold$17.1K
Nov 25, 2025BCAX Bicara Therapeutics IncSold$86.6K
Nov 25, 2025BCAX Bicara Therapeutics IncBought (not open market)—
Nov 25, 2025BCAX Bicara Therapeutics IncBought (not open market)—
Nov 24, 2025BCAX Bicara Therapeutics IncBought (not open market)—
Nov 24, 2025BCAX Bicara Therapeutics IncSold$101K
Oct 9, 2025BCAX Bicara Therapeutics IncSold$406K
Oct 9, 2025BCAX Bicara Therapeutics IncBought (not open market)—

Companies traded

  • BCAX Bicara Therapeutics Inc: 8 sales, last Apr 27, 2026

Get free alerts when David Raben files a new trade →